Ultime notizie per Avient (NYSE:AVNT) Azioni

Avient

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Avient Corp

Deep-pocketed investors have adopted a bullish approach towards Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LULU usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Lululemon Athletica. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 30% bearish. Among these notable options, 6 are puts, totaling $197,587, and 7 are calls, amounting to $662,080.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $340.0 and $410.0 for Lululemon Athletica, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Lululemon Athletica options trades today is 281.62 with a total volume of 1,259.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Lululemon Athletica's big money trades within a strike price range of $340.0 to $410.0 over the last 30 days.
<h3>Lululemon Athletica 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740768385_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$62.75</td>
<td>$58.05</td>
<td>$61.16</td>
<td>$360.00</td>
<td>$304.8K</td>
<td align="right">97</td>
<td align="right">49</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$27.25</td>
<td>$26.75</td>
<td>$26.75</td>
<td>$390.00</td>
<td>$115.0K</td>
<td align="right">428</td>
<td align="right">43</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/07/25</td>
<td>$1.28</td>
<td>$1.11</td>
<td>$1.18</td>
<td>$390.00</td>
<td>$94.4K</td>
<td align="right">124</td>
<td align="right">812</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$49.55</td>
<td>$46.7</td>
<td>$48.75</td>
<td>$390.00</td>
<td>$48.7K</td>
<td align="right">544</td>
<td align="right">10</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$42.95</td>
<td>$38.6</td>
<td>$39.95</td>
<td>$340.00</td>
<td>$39.9K</td>
<td align="right">12</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Lululemon Athletica</h3>
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Having examined the options trading patterns of Lululemon Athletica, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Lululemon Athletica's Current Market Status</h3>
<ul>
<li>With a volume of 547,510, the price of LULU is down -0.33% at $360.96. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>What Analysts Are Saying About Lululemon Athletica</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $500.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Lululemon Athletica with a target price of $500. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lululemon Athletica with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

LULU

Smart Money Is Betting Big In LULU Options

Wells Fargo analyst Vik Chopra maintains Solventum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>) with a Equal-Weight and raises the price target from $73 to $75.

News

Price Target

Analyst Ratings

SOLV

Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $75

Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 57% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $1,135,204 and 7, calls, for a total amount of $483,749.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $60.0 for Moderna over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Moderna stands at 3878.9, with a total volume reaching 3,512.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Moderna, situated within the strike price corridor from $30.0 to $60.0, throughout the last 30 days.
<h3>Moderna Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740768380_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$6.2</td>
<td>$6.0</td>
<td>$6.15</td>
<td>$30.00</td>
<td>$615.0K</td>
<td>1.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.05</td>
<td>$6.95</td>
<td>$7.05</td>
<td>$30.00</td>
<td>$282.0K</td>
<td>13.7K</td>
<td>408</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.75</td>
<td>$2.53</td>
<td>$2.74</td>
<td>$40.00</td>
<td>$134.1K</td>
<td>4.0K</td>
<td>569</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.4</td>
<td>$3.25</td>
<td>$3.4</td>
<td>$45.00</td>
<td>$98.9K</td>
<td>6.6K</td>
<td>7</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$5.45</td>
<td>$5.35</td>
<td>$5.35</td>
<td>$35.00</td>
<td>$96.2K</td>
<td>7.4K</td>
<td>543</td>
</tr>
</tbody>
</table>

<h3>About Moderna</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
<h3>Current Position of Moderna</h3>
<ul>
<li>Currently trading with a volume of 4,492,595, the MRNA's price is down by -2.28%, now at $30.38. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 62 days.</li>
</ul>
<h3>Expert Opinions on Moderna</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $49.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $78. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Moderna with a target price of $34. 
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $40. 
&#x2A; Reflecting concerns, an analyst from Barclays lowers its rating to Equal-Weight with a new price target of $45.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

MRNA

Moderna Unusual Options Activity

Alkami Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKT#NASDAQ">ALKT</a>) stock gained Friday after Wall Street analysts rerated it after its <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/44036914/alkami-technology-beats-q4-estimates-strengthens-digital-banking-platform-with-400-million-fintech-acquisition" rel="noreferrer noopener">fourth-quarter report</a> on Thursday.
The company reported fourth-quarter revenue of $89.66 million, above&nbsp;the consensus of $89.65 million.
Adjusted EPS of 11 cents exceeded the consensus of 8 cents.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/02/44011152/payoneer-q4-17-revenue-growth-22-5-billion-in-transactions-b2b-payments-up-37-revenue-target-surges" target="_blank" rel="noreferrer noopener">Payoneer Q4: 17% Revenue Growth, $22.5 Billion In Transactions, B2B Payments Up 37%, Revenue Target Surges</a>
Alkami Technology projects a first-quarter revenue of $93.5 million-$95 million compared to the consensus of $95.03 million.
JPMorgan analyst Alexei Gogolev remained Overweight on Alkami Technology with a <a href="https://www.benzinga.com/quote/ALKT/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $45</a>.
Gogolev noted the fourth-quarter results as solid, reflected through robust market share gains. Fiscal 2025E revenue growth and EBITDA on an organic basis were broadly in line with the consensus, implying an impressive 24% growth and five percentage point EBITDA margin expansion to over 13%. 
However, the key focus of today&#8217;s announcement was the acquisition of MANTL, a premier account opening solution, which will help Alkami Technology&#8217;s FIs acquire new customers. The purchase price is equivalent to ~13% of Alkami Technology&#8217;s market cap but will expand its digital user base by 40%, allowing for an even more robust cross-sell opportunity.
The acquisition also turns Alkami Technology into a front-to-back service provider in the digital banking space, providing an opportunity to grab more market share.
Gogolev projected first-quarter revenue of $94 million and adjusted EPS of 9 cents.
Price Action: ALKT stock is up 5.67% at $30.48 at the last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/44008324/echostar-q4-3-97-billion-revenue-narrows-pay-tv-subscriber-losses-focuses-on-high-quality-users-wireless-growth" target="_blank" rel="noreferrer noopener">EchoStar Q4: $3.97 Billion Revenue, Narrows Pay-TV Subscriber Losses, Focuses On High-Quality Users, Wireless Growth</a></li>
</ul>
Image: Shutterstock

Reiteration

Trading Ideas

ALKT

Alkami Growth Accelerates With MANTL Deal, Boosts Digital Banking And Cross-Sell Potential: Analyst

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a>
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week ending Feb. 28:
Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>): The specialty grocery retailer returns to the Stock market Index after appearances in November 2024 <a href="https://www.benzinga.com/25/01/43066466/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">and January 2025</a>. The company recently <a href="https://investors.sprouts.com/news/news-details/2025/Sprouts-Farmers-Market-Inc.-Reports-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx">reported </a>quarterly financial results with earnings per share and revenue each beating Street consensus estimates. The company has beaten both earnings per share and revenue estimates in four straight quarters. Sprouts is guiding for net sales growth of 10.5% to 12.5% in 2025 with comparable store sales growth of 10% to 11% for the full year. Several analysts <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">raised their price targets</a> on the stock after the earnings report. The retailer continues to draw strong interest from investors and unit expansion and net sales growth could continue to boost shares, which are up over 130% in the last year.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339.png" alt="" class="wp-image-804182" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122111/Screenshot-339-768x386.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
IonQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>): The quantum computing company saw strong interest from readers during the week on the heels <a href="https://www.benzinga.com/news/management/25/02/43993251/ionq-q4-eps-miss-500-million-offering-ceo-appointment-acquires-stake-in-id-quantique-details">of quarterly earnings</a> and a CEO change announcement. The company missed analyst estimates for earnings per share while beating revenue estimates in the quarter. The company has beaten revenue estimates in more than 10 straight quarters.
"We had IonQ's best year yet in 2024, exceeding the high ends of both our bookings and revenue guidance ranges and making truly significant technical strides," IonQ executive chair Peter Chapman said.
Along with quarterly financial results, the company announced an at-the-market equity offering of up to $500 million. The company also announced two agreements with SK Telecom and ID Quantique.
Perhaps the biggest news was the announcement that Chapman will transition from the CEO role to executive chairman with Board of Directors member Niccolo de Masi, who helped take IonQ <a href="https://www.benzinga.com/m-a/21/03/20054892/first-pure-play-quantum-computing-company-comes-public-what-investors-should-know-about-ionq">public via SPAC merger</a>, becoming the company's new president and CEO.
Shares fell on the week, but remain up over 120%. Investors will likely be closely following the next growth story with new leadership as quantum computing remains a hot investment theme.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="510" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340.png" alt="" class="wp-image-804183" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122130/Screenshot-340-768x392.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Keurig Dr Pepper Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>): The beverage company saw strong interest from readers after reporting <a href="https://www.benzinga.com/25/02/43940008/keurig-dr-pepper-q4-earnings-beat-estimates-stock-gains">quarterly financial results</a>. The company's earnings per share beat Street consensus estimates, continuing a trend that includes six beats and four in-line numbers for earnings per share in the last 10 quarters. The company's revenue beat analyst estimates and has now topped analyst estimates in seven of the last 10 quarters. Among the highlights in the report was a 10.3% year-over-year increase for the company's US Refreshment Beverages segment. The beverage company cited strong brand awareness <a href="https://www.benzinga.com/25/02/43966231/keurig-dr-peppers-dirty-soda-success-social-media-fuels-eighth-consecutive-year-of-market-share-growth">on social media </a>and Dr. Pepper hitting market share growth for an eighth consecutive year.
The company also announced a <a href="https://www.benzinga.com/news/25/02/44010283/why-keurig-dr-pepper-kdp-shares-are-falling">secondary public offering</a> of 73 million shares through a subsidiary of JAB Holding Company. After the offering, JAB will hold around 10.7% of KDP's outstanding stock. The sale could dilute shares and also signal that JAB believes shares are fairly valued or overvalued.
Several analysts<a href="https://www.benzinga.com/quote/KDP/analyst-ratings"> raised their price targets</a> on the beverage stock after the earnings report.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1001" height="507" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341.png" alt="" class="wp-image-804184" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341.png 1001w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122145/Screenshot-341-768x389.png 768w" sizes="(max-width: 1001px) 100vw, 1001px" /></a></figure>
Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>): The residential REIT saw strong interest from readers during the week, which comes after the company announced an<a href="https://www.benzinga.com/news/large-cap/25/02/43917549/sun-communities-reaps-5-65-billion-from-safe-harbor-sale-refines-strategy"> agreement to sell </a>its interest in Safe Harbor Marinas to an affiliate of Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>). The deal will bring in proceeds of $5.5 billion after costs for Sun Communities, which the company plans to use towards debt reduction, investments in core businesses and for shareholder distributions.
An owner of manufactured homes, RV parks and marina properties, the transaction will see manufactured homes and RVs represent around 90% of the company's net operating income.
"This transaction allows Sun to focus on our core businesses which operate at high margins and produce durable income streams," Sun's Capital Allocation Committee Chair Jeff Blau said.
After the announced transaction, the company <a href="https://suncommunities.gcs-web.com/news-releases/news-release-details/sun-communities-reports-2024-fourth-quarter-and-full-year">reported </a>fourth-quarter financial results with FFO missing analyst estimates for a third straight quarter and revenue beating estimates. The company has beaten analyst revenue estimates in eight of the last 10 quarters.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342.png" alt="" class="wp-image-804185" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122201/Screenshot-342-768x387.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Liberty Formula One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONA#NASDAQ">FWONA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>): The owner of the Formula 1 racing league saw strong interest from investors during the week. The company has several upcoming catalysts including the <a href="https://x.com/netflix/status/1895504704488030389">launch </a>of the seventh season of "F1: Drive to Survive" on Netflix on March 7 and the start of the new 2025 season on March 14. The racing league is also drawing interest from Netflix for the <a href="https://www.benzinga.com/25/02/43816739/netflix-wants-more-nfl-games-after-christmas-day-success-could-league-create-bidding-war-with-cbs-fox">potential media rights</a> in the U.S. when a current deal with ESPN expires. A new American Formula 1 team will be part of <a href="https://www.benzinga.com/general/sports/24/11/42178255/formula-1-stock-hits-52-week-high-announces-11th-team-with-general-motorsandretti-global-after-max-verstappens-fourth-straight-title">the 2026 season </a>and could increase awareness for the global sports brand in the coming years. The Netflix docuseries and American race locations have helped increase viewership and awareness in the United States, a trend the league hopes will continue.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="995" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343.png" alt="" class="wp-image-804186" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/28122216/Screenshot-343-768x386.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022825&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43201590/benzinga-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-2" target="_blank" rel="noreferrer noopener">January 24</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43419547/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-52" target="_blank" rel="noreferrer noopener">January 31</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43578212/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-53" target="_blank" rel="noreferrer noopener">February 7</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/02/43900861/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-54">February 21 </a></li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a></li>
</ul>
Photo: Benzinga

Exclusives

FWONA

FWONK

IONQ

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Wells Fargo analyst Neil Kalton maintains Edison Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) with a Overweight and lowers the price target from $94 to $75.

Wells Fargo Maintains Overweight on Edison Intl, Lowers Price Target to $75

Wells Fargo analyst Finian O'Shea maintains Trinity Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIN#NASDAQ">TRIN</a>) with a Underweight and raises the price target from $13 to $14.

TRIN

Wells Fargo Maintains Underweight on Trinity Cap, Raises Price Target to $14

WIIM

WW international shares are trading lower. The company reported Q4 financial results.

Wells Fargo analyst Finian O'Shea maintains BlackRock TCP Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCPC#NASDAQ">TCPC</a>) with a Underweight and lowers the price target from $8 to $7.5.

TCPC

Wells Fargo Maintains Underweight on BlackRock TCP Cap, Lowers Price Target to $7.5

Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDRX#NASDAQ">GDRX</a>) with a Overweight and lowers the price target from $9 to $8.

GDRX

Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $8

Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFX#NYSE">TFX</a>) with a Equal-Weight and lowers the price target from $214 to $146.

Wells Fargo Maintains Equal-Weight on Teleflex, Lowers Price Target to $146

President Donald Trump and Vice President JD Vance engaged in a tense exchange with Ukrainian President Volodymyr Zelenskyy during a White House meeting, where discussions on <a href="https://www.benzinga.com/topic/ukraine">military aid and diplomacy</a> took a confrontational turn. 
The gathering, originally set to finalize a U.S.-Ukraine agreement on critical mineral supplies, quickly escalated when Vance accused Zelenskyy of being disrespectful. Trump, raising his voice, warned Zelenskyy that he was &#8220;gambling with World War III,&#8221; as CNBC <a href="https://www.cnbc.com/2025/02/28/trump-vance-and-zelenskyy-clash-at-white-house-ukraine-meeting.html">reports</a>.
What Happened: Zelenskyy's visit to Washington, D.C., was expected to reinforce Ukraine's partnership with the U.S. in its ongoing defense efforts against Russian aggression. However, the dialogue shifted when Trump and Vance questioned Ukraine's diplomatic strategies, with Vance suggesting that prior U.S. policies had only fueled further conflict. 
Zelenskyy countered by emphasizing Russia's repeated breaches of ceasefire agreements, leading to a heated back-and-forth over what path forward would bring about peace.
Trump pushed back against Zelenskyy's warnings about future global instability, telling him, &#8220;You're in no position to dictate what we're gonna feel.&#8221; 
The dramatic moment underscored the friction in U.S. foreign policy discussions under the Trump administration, particularly regarding military aid and negotiations with Russia.
Also Read: <a href="https://www.benzinga.com/markets/25/02/44034579/trump-plans-big-deals-to-offset-chinas-belt-and-road-initiative-the-us-wants-to-reverse-all-of-that-says-rubio">Trump Plans &#8216;Big Deals&#8217; To Offset China&#8217;s Belt And Road Initiative: US Wants To &#8216;Reverse All Of That&#8217;, Says Rubio</a>
Why It Matters: The confrontation highlights a growing divide in how U.S. leaders approach support for Ukraine, with Trump and Vance advocating for alternative diplomatic solutions while Zelenskyy pushes for continued backing against Russian forces. 
The debate over military assistance and diplomatic engagement remains at the forefront of international security concerns, shaping NATO strategies and influencing global defense spending.
Amid these developments, U.K. Prime Minister Keir Starmer's recent visit to Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) in Washington, D.C., reflects a broader push for AI-driven defense initiatives in response to the ongoing Russia-Ukraine conflict. Starmer, alongside Trump, announced significant increases in military budgets, reinforcing the strategic alignment between the U.S. and the U.K. on <a href="https://www.benzinga.com/markets/equities/25/02/44032909/palantir-ceo-alex-karp-meets-keir-starmer-as-uk-pm-and-trump-push-for-increased-defense-spending-amid-ukraine-war">defense technology investments</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44049626/key-inflation-measure-falls-in-january-should-catch-the-feds-attention-expert-says">Key Inflation Measure Falls In January: &#8216;Should Catch The Fed&#8217;s Attention,&#8217; Economist Says</a></li>
</ul>
Image created using Shutterstock photos.

Eurozone

Global

PLTR

White House Meeting Turns Tense As Trump Warns Zelenskyy: 'You're Gambling With World War III'

Wells Fargo analyst Neil Kalton maintains FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) with a Equal-Weight and lowers the price target from $48 to $41.

Wells Fargo Maintains Equal-Weight on FirstEnergy, Lowers Price Target to $41

J.P. Morgan analyst Matthew R. Boss reiterated an <a target="_blank" href="https://www.benzinga.com/quote/FUN/analyst-ratings" rel="noreferrer noopener">Underweight rating</a> on the shares of Six Flags Entertainment Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a price forecast of $46.00.
FUN&#8217;s fourth-quarter EBITDA fell approximately 30% <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/02/44006051/six-flags-entertainment-q4-sales-miss-estimates-ceo-highlights-cost-synergies" rel="noreferrer noopener">short of the Street&#8217;s estimate of $190 million.</a>
The miss was driven by both revenue and cost discrepancies, with revenue increasing 3.6% year-over-year to $687 million, below the Street&#8217;s forecast of $704 million. According to the analyst, higher total costs resulted in an EBITDA margin of 19.0%, well below the Street&#8217;s 27.0% estimate.
On attendance, FUN reported a total of 10.7 million visitors, marking a 6.2% year-over-year increase, slightly missing the Street&#8217;s projected 6.5% growth.
Management explained that the 576,000 fewer visits at legacy Cedar Fair were due to a calendar shift, resulting in &#8220;core&#8221; Cedar Fair attendance growth of 8%.
Management reported positive early demand trends for fiscal year 2025, with a 2% year-over-year increase in attendance for the first two months.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/44042800/plug-power-ties-executive-compensation-plan-to-stock-performance" rel="noreferrer noopener">Plug Power&#8217;s High-Stakes Move: Executives Can Take Up To 75% Of Pay In Company Stock</a>
The analyst highlighted that management reiterated its target of 55 million attendees by 2027, describing 2025 as a volume-focused year that will contribute to long-term growth.
The company expects a 3% compound annual growth rate (CAGR) from 2025 to 2027, with 2025 likely below this average, while 2026 and 2027 should see higher growth, driven by ongoing investments to enhance the guest experience.
Management emphasized that in 2025, its primary focus is driving volume, which often involves being less aggressive on pricing, though price increases will still be considered.
As a result, growth in admissions per capita is expected to face downward pressure, likely resulting in negative year-over-year growth, compared to the Street&#8217;s forecast of +0.8%.
While the combined entity of FUN, with 42 parks, including 27 amusement parks and 15 water parks, is well-positioned within the regional theme park sector, benefiting from geographic diversification and the opportunity to enhance the guest experience, the analyst notes these advantages are already reflected in the current valuation.
Additionally, the analyst identifies several potential risks over the next few years, including: challenges in regaining attendance alongside possible pricing pressure on admissions and in-park spending, a higher cost base, excluding synergies, as the two brands are starting from different points, and an elevated capital expenditure cycle required to improve Six Flags&#8217; assets, which could pressure free cash flow and capital allocation, especially given current debt leverage of around 4.8x.
Price Action: FUN shares are trading higher by 2.35% at $44.38 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/44041348/werides-robobus-rolls-out-in-france-with-renault-beti-backing-details" target="_blank" rel="noreferrer noopener">WeRide&#8217;s Robobus Rolls Out In France With Renault &amp; Beti Backing: Details</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Entertainment

General

Six Flags' Stock Reflects Best-Case Scenario—Analyst Warns Of Growth & Cost Risks

Wells Fargo analyst Aaron Rakers maintains Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) with a Overweight and lowers the price target from $160 to $150.

DELL

Wells Fargo Maintains Overweight on Dell Technologies, Lowers Price Target to $150

BSVN

BANK7 Announces Acquisition Of First American Mortgage, Terms Not Disclosed

<a href="https://www.theinformation.com/articles/amazon-plans-global-expansion-for-haul-its-temu-rival" title="https://www.theinformation.com/articles/amazon-plans-global-expansion-for-haul-its-temu-rival">https://www.theinformation.com/articles/amazon-plans-global-expansion-for-haul-its-temu-rival</a>

AMZN

Citigourp Global Markets 2% Protected Notes Linked To The Djia

'Amazon Plans Global Expansion For Haul, Its Temu Rival' - The Information

CoreWeave, a cloud computing firm backed by Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), is racing <a href="https://www.benzinga.com/topic/ipo">toward an IPO</a>. 
It aims to raise $4 billion at a valuation north of $35 billion.
CoreWeave could file for a U.S. listing within a week, <a href="https://www.bloomberg.com/news/articles/2025-02-26/ai-cloud-firm-coreweave-eyes-filing-4-billion-ipo-within-a-week">reported</a> Bloomberg, setting the stage for one of the year's most anticipated debuts.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/44040632/ionq-ceo-fires-back-at-nvidias-jensen-huang-we-remain-the-800-pound-guerrilla">IonQ CEO Fires Back At Nvidia&#8217;s Jensen Huang: &#8216;We Remain The 800 Pound Guerrilla&#8217;</a>
<h2 class="wp-block-heading">From Crypto To AI Powerhouse</h2>
Originally a cryptocurrency mining outfit, CoreWeave pivoted to AI in 2019 and hasn't looked back. 
The company was an early and aggressive buyer of Nvidia Corp's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GPUs, amassing a staggering 300,000 chips — now the backbone of AI model training worldwide.
This strategic bet has paid off, with revenues skyrocketing from $25 million in 2022 to $2 billion in 2024.
<h2 class="wp-block-heading">Wall Street's Newest Darling?</h2>
Morgan Stanley, Goldman Sachs, and JPMorgan are steering the IPO, according to the <a href="https://www.ft.com/content/579176c5-a769-4102-8010-3965c4b717a7">Financial Times</a>. 
Investor appetite is already being tested. While the company has serious backers — Nvidia, Coatue, Jane Street, and Fidelity — it also carries a hefty $11 billion debt load, much of it backed by its prized Nvidia chips.
<h2 class="wp-block-heading">A Shifting AI Landscape</h2>
CoreWeave's biggest customer, Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), has committed over $10 billion through 2030, but there's a catch &#8211; Microsoft's AI infrastructure strategy is evolving.
With reports of data center contracts being unwound, investors are questioning whether CoreWeave can sustain its meteoric rise.
<h2 class="wp-block-heading">The Stakes Are High</h2>
As AI demand surges, CoreWeave's IPO will be a litmus test for the "neocloud" market. 
If it lands smoothly, it could validate the booming GPU-rental business. If not, it may signal turbulence ahead in AI's high-stakes gold rush.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/44043021/tesla-the-only-magnificent-seven-stock-in-freefall-can-it-reverse-course" target="_blank" rel="noreferrer noopener">Tesla: The Only Magnificent Seven Stock In Freefall &#8211; Can It Reverse Course?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Long Ideas

IPOs

Tech

MSFT

NVDA

Nvidia-Backed CoreWeave Eyes $4 Billion IPO: Is This AI's Next Big Test?

Investors with a lot of money to spend have taken a bullish stance on CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CVS, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for CVS Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 40%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $243,252, and 6 are calls, for a total amount of $485,932.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $70.0 for CVS Health, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CVS Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CVS Health's significant trades, within a strike price range of $50.0 to $70.0, over the past month.
<h3>CVS Health Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740767456_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$16.35</td>
<td>$16.15</td>
<td>$16.15</td>
<td>$50.00</td>
<td>$161.5K</td>
<td>327</td>
<td align="right">100</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$7.5</td>
<td>$7.35</td>
<td>$7.35</td>
<td>$62.50</td>
<td>$154.3K</td>
<td>167</td>
<td align="right">212</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$3.25</td>
<td>$3.15</td>
<td>$3.15</td>
<td>$62.50</td>
<td>$90.7K</td>
<td>2.2K</td>
<td align="right">1</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$67.50</td>
<td>$77.3K</td>
<td>1.2K</td>
<td align="right">0</td>
</tr>
<tr>
<td>CVS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.15</td>
<td>$6.9</td>
<td>$7.15</td>
<td>$67.50</td>
<td>$62.2K</td>
<td>1.4K</td>
<td align="right">89</td>
</tr>
</tbody>
</table>

<h3>About CVS Health</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
<h3>Current Position of CVS Health</h3>
<ul>
<li>With a volume of 4,111,017, the price of CVS is down -0.47% at $64.18. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 61 days.</li>
</ul>
<h3>What The Experts Say On CVS Health</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $75.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on CVS Health, which currently sits at a price target of $76. 
&#x2A; An analyst from Barclays persists with their Overweight rating on CVS Health, maintaining a target price of $73. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for CVS Health, targeting a price of $81. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on CVS Health, which currently sits at a price target of $73. 
&#x2A; Showing optimism, an analyst from Leerink Partners upgrades its rating to Outperform with a revised price target of $75. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest CVS Health options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Looking At CVS Health's Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Roku.
Looking at options history for Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $316,703 and 4, calls, for a total amount of $161,765.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $105.0 for Roku over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Roku's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Roku's significant trades, within a strike price range of $70.0 to $105.0, over the past month.
<h3>Roku Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740767452_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$4.8</td>
<td>$4.3</td>
<td>$4.4</td>
<td>$82.00</td>
<td>$118.8K</td>
<td>22</td>
<td align="right">182</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$7.95</td>
<td>$7.75</td>
<td>$7.75</td>
<td>$80.00</td>
<td>$72.0K</td>
<td>1.8K</td>
<td align="right">165</td>
</tr>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$4.8</td>
<td>$4.65</td>
<td>$4.65</td>
<td>$87.00</td>
<td>$62.7K</td>
<td>891</td>
<td align="right">462</td>
</tr>
<tr>
<td>ROKU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$7.9</td>
<td>$7.4</td>
<td>$7.87</td>
<td>$90.00</td>
<td>$49.7K</td>
<td>160</td>
<td align="right">74</td>
</tr>
<tr>
<td>ROKU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$7.95</td>
<td>$7.75</td>
<td>$7.85</td>
<td>$80.00</td>
<td>$31.4K</td>
<td>1.8K</td>
<td align="right">72</td>
</tr>
</tbody>
</table>

<h3>About Roku</h3>
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.
Following our analysis of the options activities associated with Roku, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Roku</h3>
<ul>
<li>Trading volume stands at 1,160,607, with ROKU's price up by 0.06%, positioned at $81.54.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 55 days.</li>
</ul>
<h3>Professional Analyst Ratings for Roku</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $107.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from B of A Securities persists with their Buy rating on Roku, maintaining a target price of $120. 
&#x2A; An analyst from Jefferies has elevated its stance to Hold, setting a new price target at $100. 
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $95. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Roku, targeting a price of $90. 
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on Roku, which currently sits at a price target of $130. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Roku options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Comments

Avient

Notizie

Ultime notizie per Avient (NYSE:AVNT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO